【4550】日水製薬〔上場廃止〕

ー(上場廃止)臨床診断薬、産業検査薬、OTC薬。親会社は日本水産。

東証プライム

医薬品医薬

＞

その他医療・医薬品医他

業績予想修正履歴

{{models[key].tabname}}

決算期	日付	予・実	売上高 (百万円)	対前回	修正率	修正率	営業利益 (百万円)	対前回	修正率	修正率	経常利益 (百万円)	対前回	修正率	修正率	当期利益 (百万円)	対前回	修正率	修正率
2023.03	2022/10/27	Q2予	13,600	→	0.0%	0.0%	1,360	→	0.0%	0.0%	1,450	→	0.0%	0.0%	970	→	0.0%	0.0%
2023.03	2022/07/27	Q1予	13,600	→	0.0%	0.0%	1,360	-	-	-	1,450	→	0.0%	0.0%	970	→	0.0%	0.0%
2023.03	2022/05/10	当初予	13,600	-	-	-	-	-	-	-	1,450	-	-	-	970	-	-	-
2022.03	2022/05/10	実	16,657	↑	+1.0%	+38.8%	1,564	↑	+4.3%	+93.1%	1,593	↑	+4.1%	+65.9%	1,146	↑	+5.1%	+73.6%
2022.03	2022/03/17	修正予	16,500	↑	+15.0%	+37.5%	1,500	↑	+18.1%	+85.2%	1,530	↑	+8.5%	+59.4%	1,090	↑	+11.2%	+65.2%
2022.03	2022/01/27	Q3予	14,350	→	0.0%	+19.6%	1,270	→	0.0%	+56.8%	1,410	→	0.0%	+46.9%	980	→	0.0%	+48.5%
2022.03	2021/10/28	修正予	14,350	↑	+19.6%	+19.6%	1,270	↑	+56.8%	+56.8%	1,410	↑	+46.9%	+46.9%	980	↑	+48.5%	+48.5%
2022.03	2021/07/29	Q1予	12,000	→	0.0%	0.0%	810	→	0.0%	0.0%	960	→	0.0%	0.0%	660	→	0.0%	0.0%
2022.03	2021/05/12	当初予	12,000	-	-	-	810	-	-	-	960	-	-	-	660	-	-	-
2021.03	2021/05/12	実	12,384	↑	+0.0%	+19.1%	793	↑	+0.4%	+25.9%	944	↑	+0.4%	+29.3%	648	↑	+1.2%	+32.2%
2021.03	2021/04/15	修正予	12,380	↑	+19.0%	+19.0%	790	↑	+25.4%	+25.4%	940	↑	+28.8%	+28.8%	640	↑	+30.6%	+30.6%
2021.03	2021/01/28	Q3予	10,400	→	0.0%	0.0%	630	→	0.0%	0.0%	730	→	0.0%	0.0%	490	→	0.0%	0.0%
2021.03	2020/10/29	当初予	10,400	-	-	-	630	-	-	-	730	-	-	-	490	-	-	-
2020.03	2020/05/12	実	12,773	→	0.0%	-4.0%	1,144	→	0.0%	-14.0%	991	→	0.0%	-30.2%	401	→	0.0%	-60.5%
2020.03	2020/04/30	修正予	12,773	↓	-4.0%	-4.0%	1,144	↓	-14.0%	-14.0%	991	↓	-30.2%	-30.2%	401	↓	-60.5%	-60.5%
2020.03	2020/02/03	Q3予	13,300	→	0.0%	0.0%	1,330	→	0.0%	0.0%	1,420	→	0.0%	0.0%	1,014	→	0.0%	0.0%
2020.03	2019/10/30	Q2予	13,300	→	0.0%	0.0%	1,330	→	0.0%	0.0%	1,420	→	0.0%	0.0%	1,014	→	0.0%	0.0%
2020.03	2019/07/30	Q1予	13,300	→	0.0%	0.0%	1,330	→	0.0%	0.0%	1,420	→	0.0%	0.0%	1,014	→	0.0%	0.0%
2020.03	2019/05/10	当初予	13,300	-	-	-	1,330	-	-	-	1,420	-	-	-	1,014	-	-	-
2019.03	2019/05/10	実	12,549	↓	-3.5%	-3.5%	1,312	↓	-15.4%	-15.4%	1,385	↓	-11.8%	-11.8%	784	↓	-8.8%	-28.7%
2019.03	2019/01/30	Q3予	13,000	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,570	→	0.0%	0.0%	860	→	0.0%	-21.8%
2019.03	2018/10/30	Q2予	13,000	→	0.0%	0.0%	1,550	→	0.0%	0.0%	1,570	→	0.0%	0.0%	860	↓	-21.8%	-21.8%
2019.03	2018/07/27	Q1予	13,000	→	0.0%	0.0%	1,550	-	-	-	1,570	→	0.0%	0.0%	1,100	→	0.0%	0.0%
2019.03	2018/05/11	当初予	13,000	-	-	-	-	-	-	-	1,570	-	-	-	1,100	-	-	-
2018.03	2018/05/11	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2018.03	2018/01/30	Q3予	13,500	→	0.0%	0.0%	1,600	→	0.0%	0.0%	1,600	→	0.0%	0.0%	1,120	→	0.0%	0.0%
2018.03	2017/10/31	Q2予	13,500	→	0.0%	0.0%	1,600	→	0.0%	0.0%	1,600	→	0.0%	0.0%	1,120	→	0.0%	0.0%
2018.03	2017/07/27	Q1予	13,500	→	0.0%	0.0%	1,600	→	0.0%	0.0%	1,600	→	0.0%	0.0%	1,120	→	0.0%	0.0%
2018.03	2017/05/09	当初予	13,500	-	-	-	1,600	-	-	-	1,600	-	-	-	1,120	-	-	-
2017.03	2017/05/09	実	12,825	→	0.0%	-1.3%	1,697	↓	-0.2%	-3.3%	1,839	↓	-0.1%	+2.2%	1,902	↑	+0.1%	+65.4%
2017.03	2017/04/27	修正予	12,825	↓	-1.3%	-1.3%	1,700	↓	-3.1%	-3.1%	1,840	↑	+2.2%	+2.2%	1,900	↑	+65.2%	+65.2%
2017.03	2017/01/30	Q3予	13,000	→	0.0%	0.0%	1,755	→	0.0%	0.0%	1,800	→	0.0%	0.0%	1,150	→	0.0%	0.0%
2017.03	2016/10/27	Q2予	13,000	→	0.0%	0.0%	1,755	→	0.0%	0.0%	1,800	→	0.0%	0.0%	1,150	→	0.0%	0.0%
2017.03	2016/10/13	当初予	13,000	-	-	-	1,755	-	-	-	1,800	-	-	-	1,150	-	-	-
2016.03	2016/05/09	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2016.03	2016/01/28	Q3予	12,300	→	0.0%	0.0%	2,000	→	0.0%	0.0%	3,900	→	0.0%	0.0%	2,500	→	0.0%	0.0%
2016.03	2015/10/29	Q2予	12,300	→	0.0%	0.0%	2,000	→	0.0%	0.0%	3,900	→	0.0%	0.0%	2,500	→	0.0%	0.0%
2016.03	2015/07/30	Q1予	12,300	→	0.0%	0.0%	2,000	-	-	-	3,900	→	0.0%	0.0%	2,500	→	0.0%	0.0%
2016.03	2015/05/08	当初予	12,300	-	-	-	-	-	-	-	3,900	-	-	-	2,500	-	-	-
2015.03	2015/05/08	実	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2015.03	2015/01/29	Q3予	12,200	→	0.0%	-9.6%	2,200	→	0.0%	-24.1%	3,700	→	0.0%	0.0%	2,400	→	0.0%	0.0%
2015.03	2014/10/30	Q2予	12,200	→	0.0%	-9.6%	2,200	→	0.0%	-24.1%	3,700	→	0.0%	0.0%	2,400	→	0.0%	0.0%
2015.03	2014/10/09	修正予	12,200	↓	-9.6%	-9.6%	2,200	↓	-24.1%	-24.1%	3,700	→	0.0%	0.0%	2,400	→	0.0%	0.0%
2015.03	2014/07/29	Q1予	13,500	→	0.0%	0.0%	2,900	→	0.0%	0.0%	3,700	→	0.0%	0.0%	2,400	→	0.0%	0.0%
2015.03	2014/05/08	当初予	13,500	-	-	-	2,900	-	-	-	3,700	-	-	-	2,400	-	-	-
2014.03	2014/05/08	実	13,141	-	-	-	2,844	-	-	-	3,643	-	-	-	2,305	-	-	-

【4550】日水製薬 〔上場廃止〕 ー(上場廃止)臨床診断薬、産業検査薬、OTC薬。親会社は日本水産。

業績予想修正履歴

【4550】日水製薬〔上場廃止〕

ー(上場廃止)臨床診断薬、産業検査薬、OTC薬。親会社は日本水産。